metformin has been researched along with Carcinosarcoma in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Carcinosarcoma: A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ezewuiro, O | 1 |
| Grushko, TA | 1 |
| Kocherginsky, M | 1 |
| Habis, M | 1 |
| Hurteau, JA | 1 |
| Mills, KA | 1 |
| Hunn, J | 1 |
| Olopade, OI | 1 |
| Fleming, GF | 1 |
| Romero, IL | 1 |
1 other study available for metformin and Carcinosarcoma
| Article | Year |
|---|---|
Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy.
Topics: Adenocarcinoma, Clear Cell; Aged; Carcinosarcoma; Cystadenocarcinoma, Serous; Endometrial Neoplasms; | 2016 |